Product NDC: | 0378-8170 |
Proprietary Name: | Dronabinol |
Non Proprietary Name: | Dronabinol |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Dronabinol |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, LIQUID FILLED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-8170 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078501 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111101 |
Package NDC: | 0378-8170-91 |
Package Description: | 60 CAPSULE, LIQUID FILLED in 1 BOTTLE, UNIT-DOSE (0378-8170-91) |
NDC Code | 0378-8170-91 |
Proprietary Name | Dronabinol |
Package Description | 60 CAPSULE, LIQUID FILLED in 1 BOTTLE, UNIT-DOSE (0378-8170-91) |
Product NDC | 0378-8170 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dronabinol |
Dosage Form Name | CAPSULE, LIQUID FILLED |
Route Name | ORAL |
Start Marketing Date | 20111101 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | DRONABINOL |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] |